Los Angeles, CA – Mabswitch Inc, a pioneering biotechnology company at the forefront of cutting-edge cancer immunotherapies, is proud to announce that it has been awarded a Small Business Innovation Research (SBIR) Phase 1 grant by the National Cancer Institute (NCI). This grant will support Mabswitch’s groundbreaking project, titled “SaefCAR: Read more…
Mabswitch was awarded the Bristol Myers Squibb Golden Ticket. The award provides one year of fully paid individual laboratory bench space and membership at BioLabs@NYULangone, a fully equipped, laboratory-based incubator in Manhattan with facilities, support and equipment designed to accelerate early-stage startups in the life sciences and biopharma spaces. Mabswitch Read more…
The MBC BioLabs Diversity Golden Ticket supported by AbbVie award provides lab space fitted with state-of-the-art research equipment, professional support staff, conference room space for meetings, and a vibrant, collaborative community to share ideas and expertise with other exciting life science companies. The Golden Ticket is awarded to early-stage companies Read more…
MabSwitch™ is an awardee of the 2021 Inspire QuickFire Challenge for Diverse Innovators for its approach to create innovative solutions for patients. The Inspire QuickFire Challenge is a joint program of California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, AbbVie, 5AM Ventures, and Johnson & Johnson Read more…